IDEXX Laboratories, Inc. (IDXX) stock analysis

Healthcare · Diagnostics & Research

From the 10-K filed 2026-02-20

Business type: Franchise

How it makes money

Veterinarians pay for recurring consumables, which drives higher profit margins than selling the instruments themselves.

Veterinarians purchase single-use test kits and chemical consumables as part of ongoing care.

These recurring sales generate significantly higher gross margins than the initial sale of diagnostic hardware.

What protects it: the moat

Management claims that communicating product value helps maintain premium pricing against lower-priced competitors.

The company attempts to justify higher prices by emphasizing the medical value of its products. This differentiates its offerings from competitors who sell simpler, cheaper alternatives.

What growth costs

IDEXX must reinvest in new laboratory analyzers to grow its installed base and drive recurring sales.

The company must constantly develop new analyzers and expand its global sales and logistics networks. This investment is necessary to expand the number of machines in use by veterinarians.

What could damage it

A disruption in third-party supply chains could prevent the company from selling products and delivering software.

Reliance on outside suppliers creates a risk where a supply failure stops the company from delivering both its physical products and its cloud-based software.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

More on IDXX

Other companies in Diagnostics & Research